Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xarelto
Pharma
Bayer's pharma division sees one more year of declining sales
Bayer’s growth drivers—Nubeqa and Kerendia—are performing better than anticipated. But that won’t lead to growth of company's pharma business this year.
Kevin Dunleavy
Mar 4, 2026 11:35am
NIH stops Xarelto arm of stroke trial due to safety, efficacy
Feb 10, 2026 4:04pm
Bayer stays positive on newer meds as pharma sales stagnate
Nov 12, 2025 11:46am
Bayer has laid off over 12K during Bill Anderson's tenure as CEO
Aug 6, 2025 11:37am
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
May 13, 2025 11:25am
Bayer projects Xarelto's sales decline will gain steam in 2025
Mar 5, 2025 11:17am
